Journal
FRONTIERS IN IMMUNOLOGY
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2017.01825
Keywords
natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer
Categories
Funding
- NIH [R35CA197292]
- U.S. Department of Defense [CA150085]
- Minnesota Ovarian Cancer Alliance (MOCA)
- Mayo Clinic Ovarian Cancer SPORE [P50 CA136393]
- American Cancer Society [RSG-14-151-01-CCE]
Ask authors/readers for more resources
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
